# contextual query NK cells 2

Query: The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Lymphocytes.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['SKAP1', 'CD96', 'CD247', 'MCTP2', 'PARP8', 'PRKCH', 'TXK', 'SYTL3', 'CBLB', 'PTPRC']

The enrichment of the following genes—**SKAP1, CD96, CD247, MCTP2, PARP8, PRKCH, TXK, SYTL3, CBLB, PTPRC**—in lymphocytes from the glioblastoma tumor microenvironment provides insights into the **state, function, and potential interactions** of these immune cells in both tumor and normal physiological contexts.

**Key functional themes and cellular properties indicated by this gene list:**

- **T Cell Activation, Proliferation, and Signaling:**
  - **SKAP1** is a T cell–specific adaptor protein, crucial for integrating T cell receptor (TCR) signals with integrin activation (especially LFA-1), supporting effective T cell adhesion, proliferation, and immunological synapse stability[1][2]. This suggests the lymphocytes are primed for dynamic interactions, possibly for antigen recognition or migration within the microenvironment.
  - **CD247** (also known as CD3ζ) is a component of the TCR-CD3 complex, essential for TCR signaling and robust T cell activation.
  - **PTPRC** (CD45) is broadly expressed on lymphocytes and acts as a protein tyrosine phosphatase fundamental for tuning TCR and BCR signaling thresholds, thus regulating activation and development of immune cells.
  - **TXK** is a Tec family kinase enriched in Th1 cells, contributing to IFN-γ production and T cell differentiation, supporting a cytotoxic or pro-inflammatory phenotype.
  - **PRKCH** encodes Protein Kinase C eta, implicated in T cell receptor signaling and immune cell development, contributing to downstream signaling that shape cell survival and fate.

- **Immune Regulation and Checkpoint Function:**
  - **CD96** is an immune checkpoint receptor expressed on T and NK cells and can modulate immune responses by interacting with nectin-like ligands. Its upregulation may indicate efforts to restrain overactivation, consistent with immune checkpoint activity in the tumor microenvironment[3][5].
  - **CBLB** encodes an E3 ubiquitin ligase involved in setting activation thresholds by targeting signaling molecules for degradation, serving as an internal "brake" to prevent autoimmunity.

- **Cell-Cell and Cell-Matrix Interactions:**
  - Genes such as **SKAP1** and **CD96** highlight mechanisms supporting both cell adhesion (integrins) and inhibitory interactions (immune checkpoints), relevant to effective immune surveillance, migration, and immune evasion in tumors[1][2][5].

- **Signaling Adaptors and Trafficking:**
  - **SYTL3** is involved in vesicle trafficking and cytoskeletal dynamics, possibly supporting immune synapse formation and the directed secretion of cytokines or cytolytic granules.
  - **MCTP2** and **PARP8** are less characterized in lymphocytes, but may play roles in membrane biology or protein modification, hinting at regulatory processes in membrane trafficking or stress responses.

**Implications for State and Interactions:**

- The enrichment of adaptor proteins, kinases, and checkpoint molecules suggests **active, potentially proliferating lymphocytes** equipped for both rapid response and regulatory restraint.
- The signature fits a **mix of effector and regulatory states**, with molecules supporting both **activation (TCR, integrins, kinases)** and **inhibition (CD96, CBLB)**.
- These genes are involved in **normal immune cell development, activation, migration, and tissue surveillance**. In the tumor context, they may reflect cells responding to antigenic challenge, participating in immune surveillance or being actively restrained via checkpoints.

**In summary:**  
This profile is characteristic of **antigen-experienced, regulated T lymphocytes** with robust signaling machinery, capable of both effector and modulatory functions, and prepared for complex interactions with tumor and stromal cells. The simultaneous presence of activation and inhibition markers suggests ongoing immune engagement, with the potential for both anti-tumor activity and immune exhaustion or suppression depending on the signaling context and the balance of activating versus inhibitory cues in the microenvironment[2][3][5].



## References

- [1] Immune adaptor SKAP1 acts a scaffold for Polo-like kinase 1 (PLK1) for the optimal cell cycling of T-cells https://pmc.ncbi.nlm.nih.gov/articles/PMC6639320/ 2019-07-18 None
- [2] Multi-functional adaptor SKAP1: regulator of integrin activation, the stop-signal, and the proliferation of T cells https://pmc.ncbi.nlm.nih.gov/articles/PMC10264576/ 2023-05-31 None
- [3] CD96 Correlates With Immune Infiltration and Impacts Patient Prognosis: A Pan-Cancer Analysis https://www.frontiersin.org/articles/10.3389/fonc.2021.634617/pdf 2021-02-19 None
- [4] SKAP1 is dispensable for chemokine-induced migration of primary T-cells https://pmc.ncbi.nlm.nih.gov/articles/PMC2845813/ 2010-02-16 None
- [5] CD96 as a Potential Immune Regulator in Cancers https://www.mdpi.com/1422-0067/24/2/1303/pdf?version=1673268908 2023-01-01 None